{"id":"NCT00772928","sponsor":"Sanofi","briefTitle":"Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™","officialTitle":"Immunogenicity Assessment of Pentacel™ (Hybrid CP20/20/5/3DT-mIPV//PRP-T) When Given at Different Times From or Concurrently With a Pneumococcal Conjugate Vaccine","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2003-10","primaryCompletion":"2006-05","completion":"2006-11","firstPosted":"2008-10-15","resultsPosted":"2010-02-12","lastUpdate":"2012-02-01"},"enrollment":1167,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Diphtheria","Tetanus","Haemophilus Infection","Pertussis","Polio"],"interventions":[{"type":"BIOLOGICAL","name":"Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®","otherNames":["Pentacel™","Prevnar®"]},{"type":"BIOLOGICAL","name":"Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®","otherNames":["Pentacel™","Prevnar®"]}],"arms":[{"label":"Pentacel™ concurrently with Prevnar®","type":"EXPERIMENTAL"},{"label":"Pentacel™ staggered schedule with Prevnar®","type":"EXPERIMENTAL"}],"summary":"This study is designed to evaluate in a controlled manner the effect of Prevnar® on the immune responses of Pentacel™\n\nPrimary Objective - Stage I:\n\nTo compare the immune responses elicited by an infant series of Pentacel™ when given at different times from or concurrently with a Pneumococcal conjugate vaccine (Prevnar®).\n\nPrimary Objective - Stage II:\n\nTo compare the immune responses elicited by a 4th dose of Pentacel™ when given at different times from or concurrently with Prevnar®.","primaryOutcome":{"measure":"Percentage of Participants With 4-fold Rises in Levels of Pentacel™ Vaccine Antibody Titers Post-dose 3 When Given at Different Times or Concurrently With a Pneumococcal Conjugate Vaccine (Prevnar®)","timeFrame":"28 to 48 days post-3rd vaccination","effectByArm":[{"arm":"Pentacel™ Concurrently With Prevnar®","deltaMin":90,"sd":null},{"arm":"Pentacel™ Staggered Schedule With Prevnar®","deltaMin":90,"sd":null}],"pValues":[]},"eligibility":{"minAge":"42 Days","sex":"ALL","healthyVolunteers":true,"inclusionCount":8,"exclusionCount":10},"locations":{"siteCount":23,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":["http://www.sanofipasteur.com"]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":587},"commonTop":["Upper respiratory tract infection NOS","Otitis media NOS","Teething","Bronchiolitis","Conjunctivitis"]}}